Euronext Paris · Healthcare
Invest in ABL Texcell Diagnostics stock from India
Indian and foreign residents can buy ABL Texcell Diagnostics (ABLD) shares directly through Paasa.
By Paasa · Updated
ABL Texcell Diagnostics at a glance
- Price
- €2.38+€0.00 (0.00%)
- Market cap
- €38.25M
- Day range
- €2.38 – €2.38
- P/E
- -4.25
- Dividend yield
- 4.62%
- Volume
- 371.00
- 1 month
- +4.39%
- 6 months
- -4.80%
- YTD
- -20.67%
- 1 year
- -47.11%
- 5 years
- -12.50%
ABL Texcell Diagnostics statements, FY2017–FY2021
| Fiscal year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | €0.0 | €0.0 | €0.0 | €343.3K | €655.8K |
| Gross profit | −€101.6K | −€87.2K | −€66.5K | €59.6K | €199.0K |
| Operating income | −€102.6K | −€91.2K | −€69.3K | €2.1M | −€25.1K |
| Net income | −€140.7K | −€87.4K | −€56.6K | −€455.0K | −€25.1K |
| Earnings per share | −€0.56 | −€0.35 | −€0.23 | −€1.81 | −€0.10 |
| EBITDA | €296.0K | −€89.3K | −€62.9K | €460.7K | €903.2K |
| Total assets | €2.7M | €2.4M | €7.2M | €7.7M | €7.5M |
| Total debt | €312.0 | €1.4K | €100.2K | €180.0 | €13.9K |
| Cash and short-term investments | €2.7M | €2.4M | €7.0M | €7.2M | €1.8M |
| Shareholders' equity | €2.6M | €2.4M | €7.1M | €7.2M | €7.4M |
| Operating cash flow | −€56.7K | — | −€278.4K | €81.1K | €675.2K |
| Free cash flow | −€56.7K | — | −€278.4K | −€563.3K | €370.2K |
| Capital expenditure | €0.0 | — | €0.0 | −€644.4K | −€305.0K |
Fiscal years as reported, the latest ending 31 Dec 2021. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| GE HealthCare Technologies | GEHC | $71.45 | $32.27B |
| NSE | ALNSE.PA | €35.40 | €116.65M |
| ABIONYX Pharma | ABNX.PA | €1.62 | €70.97M |
| Baikowski | ALBKK.PA | €18.80 | €68.98M |
| Poujoulat | ALPJT.PA | €5.28 | €41.30M |
| Advicenne | ALDVI.PA | €0.63 | €9.19M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in ABL Texcell Diagnostics from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search ABLD and buy
Find ABL Texcell Diagnostics by name or by its ticker, ABLD, and place your order.
Why invest in ABL Texcell Diagnostics from India
What ABL Texcell Diagnostics does
ABL Texcell Diagnostics SA provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. The company offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S/18S RNA, hepatitis-B Virus (HBV), cytomegalovirus (CMV), herpes simplex virus (HSV), BK virus (BKV), human papillomavirus (HPV), respiratory syncytial virus (RSV), and salmonella; real time PCR assays; ultr… ABL Texcell Diagnostics operates in the Medical - Healthcare Information Services industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy ABL Texcell Diagnostics stock from India?
Yes. Indian residents and NRIs can buy ABL Texcell Diagnostics (ABLD) shares directly through Paasa. ABL Texcell Diagnostics is listed on Euronext Paris, in the Medical - Healthcare Information Services industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell ABL Texcell Diagnostics shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.